[
  {
    "ts": "2025-10-08T15:48:00+00:00",
    "headline": "McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio",
    "summary": "MCK is transforming from a traditional distributor into a specialty-driven healthcare solutions leader, focusing on oncology, biopharma services and automation while preparing to separate its Medical-Surgical unit.",
    "url": "https://finance.yahoo.com/news/mckesson-bets-oncology-biopharma-streamlines-154800117.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a4e36888-60cb-36bd-9ff8-45eda4604019",
      "content": {
        "id": "a4e36888-60cb-36bd-9ff8-45eda4604019",
        "contentType": "STORY",
        "title": "McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio",
        "description": "",
        "summary": "MCK is transforming from a traditional distributor into a specialty-driven healthcare solutions leader, focusing on oncology, biopharma services and automation while preparing to separate its Medical-Surgical unit.",
        "pubDate": "2025-10-08T15:48:00Z",
        "displayTime": "2025-10-08T15:48:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9fbd184faf399044b3daf708db81da25",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zOP0QBTzaiRh4w5CHkr79w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9fbd184faf399044b3daf708db81da25.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SocztinenBkcdmCqGzbO3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9fbd184faf399044b3daf708db81da25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mckesson-bets-oncology-biopharma-streamlines-154800117.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mckesson-bets-oncology-biopharma-streamlines-154800117.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CAH"
            },
            {
              "symbol": "COR"
            },
            {
              "symbol": "MCK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-08T12:18:00+00:00",
    "headline": "Should You Continue to Hold Bio-Techne Stock in Your Portfolio?",
    "summary": "TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.",
    "url": "https://finance.yahoo.com/news/continue-hold-bio-techne-stock-121800397.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "16cff5df-6798-3238-9d7b-0af8c17d034d",
      "content": {
        "id": "16cff5df-6798-3238-9d7b-0af8c17d034d",
        "contentType": "STORY",
        "title": "Should You Continue to Hold Bio-Techne Stock in Your Portfolio?",
        "description": "",
        "summary": "TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.",
        "pubDate": "2025-10-08T12:18:00Z",
        "displayTime": "2025-10-08T12:18:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EzN04L.MG5n2SiOn76bXjg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1EIdoTL1xBchT1nrSboC2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/continue-hold-bio-techne-stock-121800397.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/continue-hold-bio-techne-stock-121800397.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CAH"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]